Clinical Research
Filter News
Found 103,363 articles
-
Researchers from the Icahn School of Medicine at Mount Sinai evaluated data on the brains of people and found higher levels of herpes virus in the Alzheimer’s patients.
-
Concerns Rise Over Negative Impact of HEV Light on Skin as Companies Delve Into Anti-Aging Therap...
6/22/2018
Something that most everyone does multiple times a day may not be as care-free as initially thought. Taking a selfie with a smart phone can actually be harmful to your skin. -
After waiting with bated breath, Johnson & Johnson Innovation finally opened its New York City JLABS facility with 26 resident companies, including the four winners of the JLABS @ NYC QuickFire Challenge.
-
For type 1 narcolepsy, this sleep-wake instability is linked to low levels of hypocretin, also called orexin. Hypocretin is a neurotransmitter produced in the hypothalamus and has a significant role in wakefulness and regulating rapid eye movement (REM) sleep. But Harmony Biosciences has found an...
-
June 22 Research Roundup: Diabetes, Spinal Injury, Pancreatic Cancer and Cardiovascular Disease
6/22/2018
There are plenty of great scientific research stories out this week including a possible cure for diabetes, healing spinal injury and more. -
Hkbu Scholars Invent Award-winning Medical Device for Safe Growth of Neural Stem Cells Using Nanotechnology
6/22/2018
The research team of Hong Kong Baptist University (HKBU) invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells (NSCs) in vitro.
-
Massachusetts General Hospital Researcher’s Diabetes Vaccine Appears to Present Cure 8 Years Later
6/21/2018
Researchers at Massachusetts General Hospital in Boston published results from a long-term clinical trial of a tuberculosis vaccine in type 1 diabetes patients that in a long-term follow-up appears to have cured the disease. -
The Future of Bioprinting is Here: Poietis and Prometheus Team Up To Develop 3D Printing for Bones
6/21/2018
Poietis along with Prometheus, a division of Skeletal Tissue Engineering at Leuven, Belgium, announced they had entered into a two-year Collaborative Research Agreement to develop high-precision 3D Bioprinting. -
A new report highlights some concerns about the long-term commercial viability of game-changing gene therapies that can radically transform the lives of patients.
-
New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathy
6/21/2018
Acucela Inc., announced today new data on the effect of emixustat hydrochloride on retinal thickness in diabetic retinopathy (DR).
-
MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
6/21/2018
Data presented at the AACR Cancer Dormancy and Residual Disease meeting support a novel therapeutic approach to combating the spread of aggressive cancer.
-
Natera Develops Powerful Kidney Transplant Rejection Biomarker
6/21/2018
Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA analysis, announces a powerful new kidney transplant rejection biomarker and study results in collaboration with the University of California, San Francisco, a recognized leader in transplantation care. The data demonstrates superior performance of its massively-multiplexed PCR (mmPCR) technology for detecting acute rejection in kidney transplant patients.
-
Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase
6/21/2018
Appili Therapeutics Inc. announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase.
-
Alnylam to Host Fifth Annual “RNAi Roundtable” Webcast Series
6/21/2018
Alnylam Pharmaceuticals, Inc. announced today that it plans to host its 5th annual series of “RNAi Roundtable” webcasts this summer.
-
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
6/21/2018
Clinical studies with aldoxorubicin demonstrated increased progression-free survival and tumor response with low cardiotoxicity
-
LA BioMed’s Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant
6/21/2018
NIH funded research led by Dr. Rie Sakai-Bizmark has potential to save the lives of hundreds of newborn babies annually.
-
Sarepta Therapeutics shares rocketed by as much as 80 percent yesterday after the company released interim data on its experimental gene therapy AAVrh74.MHCK7.micro-Dystrophin for Duchenne muscular dystrophy (DMD).
-
The Loncar Cancer Immunotherapy Index has reduced the number of immunotherapy-focused companies from 30 to 25 and also swapped out a number of stocks as part of an effort to strengthen the index’s liquidity profile and ensure the holdings hold equal weight.
-
TG Therapeutics and Novimmune SA struck a collaborative deal worth up to $185 million on the development and commercialization of a treatment for hematologic B-cell malignancies.
-
Mauna Kea Technologies Announces Positive Results from Mayo Clinic Sponsored Prospective Multi-Center Trial in Lung Transplant Patients
6/20/2018
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe-based confocal laser endomicroscopy (pCLE) platform, today announced the publication of a prospective multicenter study (ClinicalTrials.gov Identifier: NCT01033201) that demonstrates the potential of Cellvizio to aid in the diagnosis of acute cellular rejection in lung transplant patients.